Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyResearch in context

• প্রধান লেখক: Emanuel Krebs (লেখক), Deirdre Weymann (লেখক), Cheryl Ho (লেখক), Ian Bosdet (লেখক), Janessa Laskin (লেখক), Howard J. Lim (লেখক), Stephen Yip (লেখক), Aly Karsan (লেখক), Timothy P. Hanna (লেখক), Samantha Pollard (লেখক), Dean A. Regier (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2024-12-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Summary: Background: Multi-gene panel sequencing streamlines treatment selection for advanced non-small cell lung cancer (NSCLC). Implementation continues to be uneven across jurisdictions, partly due to uncertain clinical and economic impacts. In British Columbia (BC), Canada, the public healthcare...